Exact Sciences (EXAS) Other financing activities (2017 - 2025)

Exact Sciences (EXAS) has 9 years of Other financing activities data on file, last reported at -$1.7 million in Q4 2025.

• Other financing activities for Q4 2025 came in at -$1.7 million, up 21.76% year-over-year; the trailing twelve-month figure through Dec 2025 was -$11.9 million (up 33.05% YoY), and the FY2025 annual result was -$11.9 million, up 33.05% from the prior year.
• Other financing activities rose to -$1.7 million in Q4 2025 per EXAS's latest filing, from -$1.7 million in the prior quarter.
• Over five years, Other financing activities peaked at -$417000.0 in Q4 2022 and troughed at -$11.6 million in Q2 2024.
• A 5-year average of -$2.5 million and a median of -$1.7 million in 2021 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2024 and 2025: Other financing activities sank 903.64% in 2024, then jumped 84.13% in 2025.
• A 5-year view of Other financing activities shows it stood at -$544000.0 in 2021, then climbed by 23.35% to -$417000.0 in 2022, then plunged by 443.65% to -$2.3 million in 2023, then climbed by 2.51% to -$2.2 million in 2024, then grew by 21.76% to -$1.7 million in 2025.
• Business Quant data shows EXAS's Other financing activities at -$1.7 million in Q4 2025, -$1.7 million in Q3 2025, and -$1.8 million in Q2 2025.